Last reviewed · How we verify

NCT07412431

Periodontal Health Profile in Multiple Sclerosis Patients

Not yet recruiting Last updated 17 February 2026
What this trial tests

trial in Multiple Sclerosis in 100 participants. Not yet recruiting.

Timeline
3 February 2026
Primary endpoint
5 October 2026
9 March 2027

Quick facts

Lead sponsorSaglik Bilimleri Universitesi
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment100
Start date3 February 2026
Primary completion5 October 2026
Estimated completion9 March 2027

Conditions studied

Sponsor

Saglik Bilimleri Universitesi — full company profile →

Who can join

Adults 18 to 65, any sex, with Multiple Sclerosis or Periodontitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the periodontal status of patients with Multiple Sclerosis (MS) through clinical, microbiological, and biochemical parameters. Multiple sclerosis and periodontal diseases are both chronic inflammatory conditions that may share common immunopathological pathways. The primary objective is to investigate the relationship between MS and periodontal health by comparing clinical measurements with the microbial composition and biochemical markers found in saliva samples of patients followed by the Neurology Department.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Multiple Sclerosis

Currently open trials in the same condition.

Other Saglik Bilimleri Universitesi trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07412431.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing